Altimmune Inc (NASDAQ: ALT) Seen Running Too Hot, Let’s Look At This More Closely
Currently, there are 70.68M common shares owned by the public and among those 70.48M shares have been available to trade. The company’s stock has a 5-day price change of 9.09% and 11.18% over the past three months. ALT shares are trading -38.13% year to date (YTD), with the 12-month market performance up to 184.08% higher. […]
Are Analysts Expecting A Better 2020 For Altimmune Inc (ALT)?
Altimmune Inc (ALT) concluded trading on Wednesday at a closing price of $6.87, with 3.15 million shares of worth about $21.63 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -16.42% during that period and on August 21, 2024 the price saw a loss […]
Altimmune Inc (NASDAQ: ALT): Reassessing Prospects
Altimmune Inc (ALT) concluded trading on Thursday at a closing price of $6.33, with 5.56 million shares of worth about $35.21 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -38.84% during that period and on August 08, 2024 the price saw a gain […]
Altimmune Inc (NASDAQ: ALT): Do Not Miss The Gain Train
Altimmune Inc (ALT) concluded trading on Thursday at a closing price of $6.69, with 3.41 million shares of worth about $22.79 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -28.45% during that period and on July 25, 2024 the price saw a gain […]
Altimmune Inc (NASDAQ: ALT) – Not A Clear Buying Opportunity?
Altimmune Inc (ALT) concluded trading on Thursday at a closing price of $6.55, with 3.87 million shares of worth about $25.35 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -41.36% during that period and on July 18, 2024 the price saw a loss […]
Altimmune Inc (NASDAQ: ALT) – Not A Clear Buying Opportunity?
Altimmune Inc (ALT) concluded trading on Wednesday at a closing price of $6.69, with 1.91 million shares of worth about $12.76 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -36.41% during that period and on Wednesday the price saw a loss of about […]
Gains May Be On The Menu For Altimmune Inc (NASDAQ: ALT)
Currently, there are 53.73M common shares owned by the public and among those 53.08M shares have been available to trade. Insiders at the company have transacted a total of 9 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 9 of these insider trades were purchases, […]
Altimmune Inc (NASDAQ: ALT) – Suitable For Long Term Buy?
Currently, there are 53.73M common shares owned by the public and among those 53.12M shares have been available to trade. Insiders at the company have transacted a total of 9 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 9 of these insider trades were purchases, […]
Analyst Expect Big Moves From Altimmune Inc (NASDAQ: ALT)
BlackRock Fund Advisors recently announced the acquisition of new stake in Altimmune Inc (NASDAQ:ALT). The institutional investor has increased its shareholding in the Healthcare company by 2.36% to 3.44 million shares with purchase of 79241.0 shares. This fresh investment now brings its stake to 6.40% valued currently at $38.71 million. In addition, The Vanguard Group, […]
Reassessing The Changing Outlook For Altimmune Inc (ALT)
BlackRock Fund Advisors recently announced the acquisition of new stake in Altimmune Inc (NASDAQ:ALT). The institutional investor has increased its shareholding in the Healthcare company by 2.36% to 3.44 million shares with purchase of 79241.0 shares. This fresh investment now brings its stake to 6.40% valued currently at $38.71 million. In addition, The Vanguard Group, […]
